FASEB SRC: The 6th International Conference on Retinoids
FASEB SRC:第六届类维生素A国际会议
基本信息
- 批准号:10468377
- 负责人:
- 金额:$ 2万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-01 至 2023-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAlzheimer&aposs DiseaseAmericanAreaAwardBiochemicalBiological ProcessBiologyClinicalCollaborationsDatabasesDevelopmentDiabetes MellitusDisciplineDiseaseEmbryonic DevelopmentEnsureEnzymatic BiochemistryEventFundingGoalsHealthHomeostasisHumanImmune System DiseasesImmunityImmunologistImmunologyIndividualInternationalMalignant NeoplasmsMediatingMetabolic DiseasesMetabolic dysfunctionMetabolismMolecularMolecular ImmunologyNutritionalOhioOralParticipantPathologyPharmacologyPhysiologicalPostdoctoral FellowProcessReporterReportingReproductionRequest for ApplicationsResearchResearch ActivityResearch PersonnelResearch Project GrantsRetinoid ReceptorRetinoidsScienceScientistSenior ScientistSignal TransductionSocietiesStructural BiologistTherapeuticTimeTrainingTranslational ResearchTravelUnderrepresented PopulationsUnited States National Institutes of HealthUniversitiesVisionVisualVitamin AWomanWorkbasebench to bedsidecapsulecareercell typedisorder preventionequity diversity and inclusionfundamental researchgraduate studentmeetingsnervous system disordernovelnutritionpostersregenerative biologyskin disorderstem cell biologystem cellssymposiumtraining opportunity
项目摘要
PROJECT SUMMARY / ABSTRACT
This NIH R13 application requests requesting partial funding for the 2022 Federation of American Societies for
Experimental Biology (FASEB) “6th International Conference on Retinoids” that will be held at Ohio University,
Athens, OH from June 5, 2022 to June 10, 2022. The FASEB Science Research Conference on Retinoids has
been held every other year since 1982 where the meeting planned for 2022 will be the 21st FASEB Science
Research Conference on Retinoids. This biennial research conference has been very well attended (ranging
from 100 to 200 attendees over the past 40 years) and remains the only major national and international
conference committed to focus on the studies of retinoids, and to comprehensively address the broad spectrum
of retinoid actions and application in an integrative manner. While the mechanisms of action and the biological
functions of retinoids have been intensively studied, there is an increasing need for understanding and applying
retinoids in human nutrition and diseases. Currently, a great deal of research activity is supported by the NIH
(the NIH RePORTER database indicates 2190 NIH funded individual research grants involving aspects of
retinoid/vitamin A biology). The main topics to be addressed include both basic and translational fronts of retinoid
biology: 3 sessions on retinoid mechanisms (I, Retinoid receptors, retinoid receptor-mediated biology; II, Retinoid
metabolism, homeostasis, and enzymology; III, Development, stem cell and regenerative biology); 3 sessions
on retinoids and disease (I, Immune disorders and immunology; II, Signaling and metabolic dysfunction; III,
Cancer and related pathologies), and 2 sessions on molecular therapeutics (I, Retinoid mechanisms and novel
targets; II, Rexinoids and novel pharmacological applications). The overall goal is to bring together a group of
committed investigators (senior scientists, mid-career scientists, junior scientists, postdoctoral fellows, and
graduate students), who work in diverse disciplines (as biochemists, molecular biologists, nutritional scientists,
cancer researchers, vision researchers, stem cell biologists, biophysicists, structural biologists, immunologists,
chemists, and clinicians) to present and discuss their latest research findings that share a common focus on the
retinoids. To encourage new/young investigators and trainees to attend this meeting, we plan to offer six career-
oriented training sessions and six meet-the-expert sessions. To increase visibility of early-stage investigators
and trainees through oral presentations, we plan eight speaking opportunities and twenty-nine short talk and
capsule reports presentations to be chosen from the submitted abstracts. This meeting has been strongly
supported by NIH in the past. We respectfully request partial support for the 2022 FASEB Retinoid Conference
to increase the attendance by under-represented and women scientists, trainees, postdoctoral fellows, and early-
stage investigators to facilitate entry into this research area in order to spur interdisciplinary and translational
science as well as collaborations between basic scientists and clinicians.
项目总结/摘要
该NIH R13申请要求为2022年美国学会联合会提供部分资金,
实验生物学(FASEB)“第六届维甲酸国际会议”将在俄亥俄州大学举行,
雅典,OH从2022年6月5日至2022年6月10日。FASEB维甲酸科学研究会议
自1982年以来每隔一年举行一次,计划于2022年举行的会议将是第21届FASEB科学
关于Retinoids的研究这两年一次的研究会议一直很好地参加(范围
从100到200与会者在过去的40年),仍然是唯一的主要国家和国际
会议致力于关注类维生素A的研究,并全面解决广谱
类维生素A的作用和应用的综合方式。虽然作用机制和生物学
类维生素A的功能已被深入研究,越来越需要了解和应用
维生素A在人类营养和疾病中的作用。目前,大量的研究活动得到了NIH的支持
(the NIH Reporter数据库显示,2190个NIH资助的个人研究赠款涉及以下方面:
类维生素A/维生素A生物学)。主要的研究课题包括维甲酸的基础和翻译前沿
生物学:3次类维生素A机制会议(I,类维生素A受体,类维生素A受体介导的生物学; II,类维生素A
代谢,稳态和酶学; III,发展,干细胞和再生生物学); 3次会议
关于类维生素A和疾病(I,免疫障碍和免疫学; II,信号传导和代谢功能障碍; III,
癌症和相关病理学),以及2个分子治疗学会议(I,维甲酸机制和新的
目标; II,Rexinoids和新的药理学应用)。总体目标是将一组
致力于研究人员(高级科学家,职业中期科学家,初级科学家,博士后研究员,
研究生),谁在不同的学科工作(如生物化学家,分子生物学家,营养科学家,
癌症研究人员,视觉研究人员,干细胞生物学家,生物药理学家,结构生物学家,免疫学家,
化学家和临床医生)介绍和讨论他们的最新研究成果,这些研究成果共同关注
类维生素A。为了鼓励新的/年轻的调查员和学员参加这次会议,我们计划提供六个职业-
定向培训班和六次专家会议。提高早期调查人员的知名度
通过口头报告和学员,我们计划八个演讲机会和二十九个简短的谈话,
capsule报告从提交的摘要中选择的专题介绍。这次会议强烈
在过去的一段时间里,我们恭敬地请求部分支持2022年FASEB维甲酸会议
增加代表性不足的女科学家、受训人员、博士后研究员和早期-
阶段调查,以促进进入这一研究领域,以刺激跨学科和翻译
科学以及基础科学家和临床医生之间的合作。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MAUREEN A KANE其他文献
MAUREEN A KANE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MAUREEN A KANE', 18)}}的其他基金
FASEB's "The 5th International Conference on Retinoids"
FASEB“第五届类维生素A国际会议”
- 批准号:
9993697 - 财政年份:2021
- 资助金额:
$ 2万 - 项目类别:
Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate
用仿制和参比葡萄糖酸铁钠治疗的健康受试者中铁形态的评价
- 批准号:
8875255 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:
Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate
用仿制和参比葡萄糖酸铁钠治疗的健康受试者中铁形态的评价
- 批准号:
8925792 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:
Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate
用仿制和参比葡萄糖酸铁钠治疗的健康受试者中铁形态的评价
- 批准号:
9352557 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:
Molecular determinants of retinoid metabolism in embryonic tissues
胚胎组织中类维生素A代谢的分子决定因素
- 批准号:
8839807 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:
Molecular determinants of retinoid metabolism in embryonic tissues
胚胎组织中类维生素A代谢的分子决定因素
- 批准号:
8651030 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:
Molecular determinants of retinoid metabolism in embryonic tissues
胚胎组织中类维生素A代谢的分子决定因素
- 批准号:
9036421 - 财政年份:2014
- 资助金额:
$ 2万 - 项目类别:














{{item.name}}会员




